Atlas Trials

Study Investigating a Delayed-Release Pancrelipase in Patients With Pancreatic Exocrine Insufficiency (PEI) Due to Cystic Fibrosis (CF)

Clinical trial NCT00690820 · COMPLETED

Trial details

NCT number
NCT00690820
Sponsor
Solvay Pharmaceuticals
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Cystic FibrosisPancreatic Exocrine Insufficiency
Start date
2008-06-01
Primary completion
2008-12-01
Enrollment
17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.